Stay updated on Rexlemestrocel-L in Low Back Pain Clinical Trial
Sign up to get notified when there's something new on the Rexlemestrocel-L in Low Back Pain Clinical Trial page.

Latest updates to the Rexlemestrocel-L in Low Back Pain Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov site revision identifier was updated, with no change to the clinical trial record content.SummaryDifference0.0%

- Check9 days agoChange DetectedThe study record for the Phase 3 rexlemestrocel-L chronic low back pain trial is displayed, including its eligibility criteria, interventions, outcome measures, locations, and posted results information, rather than a forbidden-access error.SummaryDifference81%

- Check30 days agoChange DetectedA site-wide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check44 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check58 days agoChange DetectedA 403 Forbidden error is now shown in place of the study record content, preventing access to the trial details. This blocks users from viewing the information on that page.SummaryDifference19%

- Check65 days agoChange DetectedThe page’s revision label has been updated to Revision: v3.7.0, replacing the previous Revision: v3.6.6; this reflects an update to the page’s version metadata rather than substantive content.SummaryDifference0.0%

Stay in the know with updates to Rexlemestrocel-L in Low Back Pain Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rexlemestrocel-L in Low Back Pain Clinical Trial page.